Single Dose of Sodium Zirconium Cyclosilicate Versus Sodium Polystyrene Sulfonate in Hospitalized Patients With Hyperkalemia

高钾血症 医学 钾 钠 养生 胃肠病学 麻醉 内科学 药理学 化学 有机化学
作者
Noah Yoo,Yong‐Bum Song,Ilya Dubinsky,Jerry Altshuler
出处
期刊:Annals of Pharmacotherapy [SAGE Publishing]
卷期号:57 (9): 1044-1052 被引量:11
标识
DOI:10.1177/10600280221141918
摘要

BACKGROUND: Sodium zirconium cyclosilicate (SZC) is an inorganic zirconium silicate compound that selectively exchanges potassium for hydrogen and sodium. "Once" doses of SZC (with option to redose) in patients with hyperkalemia in hospitalized settings have not been evaluated. We hypothesized that a once dose of SZC would be non-inferior to sodium polystyrene sulfonate (SPS) in reducing serum potassium. OBJECTIVE: The objective of our study is to evaluate the effect of a "once" dose of SZC when compared with SPS in reducing serum potassium levels. METHODS: This was a retrospective analysis of patients who received either a "once" dose of SZC or single or repeated doses of SPS for hyperkalemia. The primary endpoint was mean absolute reduction in the first serum potassium value at least 4 hours after administration. The secondary efficacy endpoints were the rate of additional potassium-lowering therapies and the rate of normokalemia within 48 hours. Safety endpoints were the incidence of electrolyte abnormalities, hypoglycemia, hypertension, hypotension, and colonic necrosis. RESULTS: < 0.0001). The proportion of patients achieving normokalemia within 48 hours and the proportion of patients receiving additional potassium-lowering therapies did not differ between groups. CONCLUSION AND RELEVANCE: The "once" dose regimen (with redose option) of SZC was non-inferior to the "once" or repeated dosing regimen of SPS with regard to absolute potassium reduction. There were no significant differences in the rate of additional potassium-lowering therapies and the rate of normokalemia at 48 hours. The incidence of hypertension was less common among patients who received SZC.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Ambition完成签到,获得积分10
1秒前
1秒前
丘比特的应助被YUEYUEHENCHEN采纳,获得10
1秒前
张续完成签到,获得积分10
2秒前
throb完成签到,获得积分10
2秒前
2秒前
降智小甜饼完成签到,获得积分10
4秒前
6秒前
科研通AI6.3的应助被笙笙采纳,获得10
6秒前
852的应助被xdlongchem采纳,获得10
6秒前
mingxi完成签到,获得积分10
7秒前
7秒前
7秒前
hhud发布了新的文献求助10
8秒前
Rain发布了新的文献求助10
8秒前
10秒前
科研通AI65的应助被激昂的如柏采纳,获得10
10秒前
11秒前
毛毛发布了新的文献求助10
11秒前
12秒前
Ichiyou完成签到,获得积分10
13秒前
14秒前
yang完成签到,获得积分10
14秒前
14秒前
Akim的应助被动听千山采纳,获得10
15秒前
15秒前
15秒前
沉静鼠鼠完成签到 ,获得积分10
15秒前
16秒前
DoubleHappiness完成签到,获得积分10
16秒前
小王小王发布了新的文献求助10
16秒前
xieroro完成签到,获得积分10
16秒前
冯琪雯雯完成签到,获得积分10
17秒前
陈志豪完成签到 ,获得积分10
17秒前
orrange发布了新的文献求助10
17秒前
18秒前
18秒前
sun完成签到,获得积分10
18秒前
zqh完成签到,获得积分10
18秒前
yang发布了新的文献求助10
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8177802
求助须知:如何正确求助?哪些是违规求助? 9568632
关于积分的说明 21799933
捐赠科研通 7772424
什么是DOI,文献DOI怎么找? 3432505
关于科研通互助平台的介绍 2556698
邀请新用户注册赠送积分活动 2478055